Chemosensitivity and chemoresistance assays: are they clinically relevant? Maurie Markman Editorial Pages: 441 - 442
Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma Kirsi Pekkola-HeinoMisa JaakkolaReidar Grénman Original Paper Pages: 452 - 456
Treatment of human hepatocellular carcinoma by fibroblast-mediated human interferon α gene therapy in combination with adoptive chemoimmunotherapy Xuetao CaoJianli WangKenzaburo Tani Original Paper Pages: 457 - 462
Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours—an experimental study in rats Stig B. HolmbergPeter L. J. NarediLarsolof R. Hafström Original Paper Pages: 463 - 468
Doxorubicin-heparin complex: reduction of cardiotoxicity of doxorubicin Yumi MizunoToshiro HaraKohji Ueda Original Paper Pages: 469 - 473
Effect of cisplatin in advanced colorectal cancer resistant to 5-fluorouracil plus (S)-leucovorin A. CassanoC. PozzoC. Barone Original Paper Pages: 474 - 477
The use of the Calvert formula to determine the optimal carboplatin dosage L. J. C. van WarmerdamS. RodenhuisJ. H. Beijnen Original Paper Pages: 478 - 486
Workshop: Active Specific Immunotherapy with Tumor Cell Vaccines V. SchirrmacherT. AhlerG. Bastert Meeting Report Pages: 487 - 489
Thirty-first Annual Meeting of the American Society of Clinical Oncology Maurie Markman Meeting Report Pages: 490 - 491
Ifosfamide treatment as a 10-day continuous intravenous infusion H. J. KeizerJ. OuwerkerkF. J. Cleton Erratum Pages: 492 - 492